SBI Securities’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47 Sell
87
-3
-3% -$6 ﹤0.01% 3586
2025
Q4
$593 Sell
90
-32
-26% -$125 ﹤0.01% 2807
2025
Q3
$375 Buy
122
+1
+0.8% +$3 ﹤0.01% 3093
2025
Q2
$194 Hold
121
﹤0.01% 3317
2025
Q1
$231 Hold
121
﹤0.01% 3170
2024
Q4
$428 Buy
+121
New +$424 ﹤0.01% 2951

Other funds holding CALC

SBI Securities's CALC Position: Q1 2026 in Review

SBI Securities reduced its CalciMedica (CALC) stake by 3.3% in Q1 2026, selling an estimated $6 and leaving 87 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #3586.

SBI Securities first reported a position in CALC in Q4 2024 and has held it in 6 quarters since. The position peaked at $593 in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • SBI Securities held 87 shares of CalciMedica worth $47 as of Q1 2026.
  • SBI Securities sold 3 CalciMedica shares in Q1 2026, an estimated $6.
  • CalciMedica made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3586 holding.
  • SBI Securities first reported a position in CalciMedica in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's CalciMedica position peaked at $593 in Q4 2025.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.